Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: Results from a population-based study

Cancer

Volumn 121, Issue 2, 2015, Pages 194-201

  Wani, Sachin ^a,b   Das, Ananya ^c   Rastogi, Amit ^b,d   Drahos, Jennifer ^e   Ricker, Winifred ^f   Parsons, Ruth ^f   Bansal, Ajay ^b,d   Yen, Roy ^a   Hosford, Lindsay ^a   Jankowski, Meghan ^a   Sharma, Prateek ^b,d   Cook, Michael B ^e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Arizona Center for Digestive Health   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

Endoscopic ultrasonography; Endoscopic ultrasound; Esophageal cancer; Positron emission tomography and computed tomography; Staging; Survival

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC THERAPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT IDENTIFICATION; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; ADENOCARCINOMA; ADULT; CANCER REGISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; KAPLAN MEIER METHOD; MEDICARE; MIDDLE AGED; MORTALITY; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICARE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84920771321     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29043     Document Type: Article

References (21)

1. Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119:1149-1158.
2. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179-1187.e1-3.
3. Eloubeidi MA, Wallace MB, Hoffman BJ, et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg. 2001;72:212-219.
4. Hulscher JB, Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306-313.
5. Pfau PR, Perlman SB, Stanko P, et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc. 2007;65:377-384.
6. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53:925-930.
7. Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol. 2005;23:4483-4489.
8. Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49:534-539.
9. van Westreenen HL, Heeren PA, van Dullemen HM, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg. 2005;9:54-61.
10. Schreurs LM, Janssens AC, Groen H, et al. Value of EUS in determining curative resectability in reference to CT and FDG-PET: the optimal sequence in preoperative staging of esophageal cancer? Ann Surg Oncol. In press.
11. Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg. 2002;74:1026-1032.
12. Gagne JJ, Glynn RJ, Avorn J, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64:749-759.
13. Das A, Chak A, Sivak MV Jr, et al. Endoscopic ultrasonography and prognosis of esophageal cancer. Clin Gastroenterol Hepatol. 2006;4:695-700.
14. Maluf-Filho F, Dotti CM, Halwan B, et al. An evidence-based consensus statement on the role and application of endosonography in clinical practice. Endoscopy. 2009;41:979-987.
15. Vazquez-Sequeiros E, Wiersema MJ, Clain JE, et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology. 2003;125:1626-1635.
16. Mortensen MB, Edwin B, Hunerbein M, et al. Impact of endoscopic ultrasonography (EUS) on surgical decision-making in upper gastrointestinal tract cancer: an international multicenter study. Surg Endosc. 2007;21:431-438.
17. Young PE, Gentry AB, Acosta RD, Greenwald BD, Riddle M. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol. 2010;8:1037-1041.
18. Ott K, Weber W, Siewert JR. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus. 2006;19:433-442.
19. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148-156.
20. Meyers BF, Downey RJ, Decker PA, et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg. 2007;133:738-745.
21. Christensen D. The Will Rogers phenomenon: roping the effects of a new cancer staging system. J Natl Cancer Inst. 2003;95:1105-1106.